Tositumomab

Drug

Pharmacological class
CD20-directed Radiotherapeutic Antibody
Legal status
Marketed formulations
Mechanism of action
CD20-directed Antibody Interaction
Radiopharmaceutical Activity
Active moieties
 

Drug ingredient

Active ingredient of formulation
Active moiety of formulation
Active moiety of drug
More specific ingredient
 

NCI Term

URI
 

BV: Therapeutic

Indication or disease
Follicular lymphoma (On the market)
Target/Biomolecule of Interest
CD20
 

BV: Product

Developed by
Technology involved
Brand Names
Bexxar
Stage of development
On the market
Edit this page

Freebase CC-BY
Source: Tositumomab on Freebase licensed under CC-BY